Received Mar 7, 2025
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| VARZOS | ZOSTER (SHINGRIX) | GLAXOSMITHKLINE BIOLOGICALS | 2 | 93KK4 | IM / LA |
Patient received dose 2 of Shingrix before recommended interval of 8 weeks from first dose. Patient was not harmed but informed their 2nd dose would be invalid according to CDC guidelines. Patient agreed to come 8 weeks from invalid dose to receive valid second dose of Shringrix.
none
HTN, HF, COPD
furosemide, atorvastatin, Jardiance, potassium, Incruse Ellipta, Albuterol HFA, Aspirin, spironolactone, carvedilol, losartan
none
n/a